DENTSPLY SIRONA Inc
XBER:DY2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
DENTSPLY SIRONA Inc
XBER:DY2
|
US |
|
Arcus Biosciences Inc
NYSE:RCUS
|
US |
|
B
|
Boston Scientific Corp
SWB:BSX
|
US |
|
C
|
Case Group AB
STO:CASE
|
SE |
|
M
|
Molina Healthcare Inc
F:MHG
|
US |
|
S
|
SandRidge Energy Inc
F:SA2D
|
US |
|
E
|
Exlservice Holdings Inc
F:LHV
|
US |
|
Regional Management Corp
F:46F
|
US |
|
B
|
Brightview Holdings Inc
F:7BV
|
US |
|
F
|
Fortescue Metals Group Ltd
XBER:FVJ
|
AU |
|
Thomson Reuters Corp
NASDAQ:TRI
|
CA |
|
S
|
Scentre Group
SWB:59S
|
AU |
Wall St Price Targets
DY2 Price Targets Summary
DENTSPLY SIRONA Inc
According to Wall Street analysts, the average 1-year price target for DY2 is 14.224 EUR with a low forecast of 9.39 EUR and a high forecast of 18.439 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DY2's stock price target?
Price Target
14.224
EUR
According to Wall Street analysts, the average 1-year price target for DY2 is 14.224 EUR with a low forecast of 9.39 EUR and a high forecast of 18.439 EUR.
What is the Revenue forecast for DENTSPLY SIRONA Inc?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 1%.
What is the Gross Profit forecast for DENTSPLY SIRONA Inc?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 1%. The projected CAGR for the next 3 years is 3%.
What is the Operating Income forecast for DENTSPLY SIRONA Inc?
Projected CAGR
27%
Over the last 13 years, the compound annual growth rate for Operating Income has been -4%. The projected CAGR for the next 3 years is 27%.
